Singulair pricing: ways to save on prescriptions - in Australia

Broad view

Montelukast, often supplied under the brand name Singulair, is a leukotriene receptor antagonist. It works by blocking leukotrienes, substances that can cause airway constriction and inflammation, so it helps reduce symptoms of asthma and allergic rhinitis. It is intended for regular use and is not suitable as an emergency reliever for sudden breathing problems.

• Available presentations in Australia include 10 mg film-coated tablets, 5 mg and 4 mg chewable tablets, and 4 mg oral granules in sachets.
• The active substance is montelukast sodium.
• Regulatory uses include ongoing asthma maintenance, prevention of exercise-induced bronchoconstriction, and symptom control for seasonal and perennial allergic rhinitis. For acute breathlessness, use your reliever inhaler and follow your asthma action plan.

Jump to page practical sections: how to accept it, costs, or how to obtain it legally in Australia.

Go back to the page's top

How to take notes efficiently

Follow the directions your prescriber has supplied. Montelukast is normally taken orally once a day at the same time every day to maintain steady control of symptoms.

• Many adults use the tablet at night for asthma control. For hay fever, choose a convenient fixed time each day.
• The tablets can be taken with meals or on an empty stomach.
• Chewable tablets should be chewed completely before swallowing.
• 10 mg film-coated tablets should be swallowed whole and not crushed or chewed.
• Granules can be poured onto the tongue or mixed with a spoonful of soft food; use immediately after opening the sachet.

The younger crowd have age-dependent dosing and formulation requirements. Read the prescription label and discuss any dosing questions with your paediatrician or pharmacist.

If you suspect an overdosed or see worrying symptoms, contact emergency services or the Poisons Information Centre in Australia on 13 11 26, or attend your nearest emergency department.

Did you forget to take the prescribed dose? See instructions when a dose is skipped.

Scroll to top

Before you kick things off

Inform your clinician or pharmacist about any of the following before initiating montelukast:

• Previous or current liver disease, including past hepatitis.
• Plans to bear a child, pregnancy, or breastfeeding.
• A history of mood, sleep, or behavioural disturbances, including anxiety, depression, nightmares, or suicidal thoughts.
• Known allergy to montelukast or any excipients. Chewable tablets may include aspartame in addition to therefore contain phenylalanine.
• Concurrent use of other medications, supplements, or herbal products, especially enzyme inducers or inhibitors such as rifampicin, carbamazepine, phenytoin, gemfibrozil, or Herbal remedy St Johns wort.

If montelukast is being considered only for allergic rhinitis, discuss the balance of benefits and potential for growth neuropsychiatric risks and credible other possibilities.

Return to the earlier section page top

Conversational subtle the act of engaging with otherss can reinforce culture.

Certain medicines can alter montelukast concentrations or be affected by it. Key examples include:

• Gemfibrozil can raise montelukast levels by inhibiting CYP2C8.
• Strong enzyme inducers such as rifampicin, rifabutin, carbamazepine, phenobarbital, phenytoin, and The plant St Johns wort may lower montelukast exposure and reduce effectiveness.
• Medicines metabolised by CYP2C8 for which interaction is possible include repaglinide and rosiglitazone; clinical consequences are uncommon but status monitoring may be advisable.
• Alcoholic beverage item and sedatives do not have a major pharmacokinetic the process of interaction but may increase sedation or dizziness in sensitive individuals.

The list is not all-inclusive. Provide your clinician with a full list of prescription and non-prescription products, vitamins, and herbal medicines.

Return again to the page top

Short term effects

Some negative pharmacologic effects require immediate medical attention. Seek urgent care if you notice:

• Significant changes in mood or behaviour including severe depression, agitation, suicidal ideation, or new/marked nightmares.
• Signs of an allergic reaction such as rash, hives, facial or tongue swelling, or breathing difficulties.
• Possible liver injury signs such as yellowing of the skin or eyes, dark urine, persistent nausea, or unexplained bleeding or bruising.
• New fever, worsening sinus or respiratory symptoms, numbness or tingling, or painful skin lumps that could suggest rare inflammatory conditions.

More common, typically mild reactions can include head discomfort, dizziness, abdominal discomfort, diarrhoea, drowsiness or disturbed sleep, and nasal symptoms.

If medication side effects are persistent or severe, contact your healthcare professional. Adverse events may be reported to the Therapeutic Goods Administration (TGA) through the appropriate processes.

Return again to this spot the page top

Ensuring safety through continuous oversight heads up notices

• Montelukast does not relieve sudden breathlessness or acute asthma attacks. Keep and use your reliever inhaler as prescribed and follow your written asthma action plan.
• Continue other prescribed maintenance therapies unless your prescriber advises otherwise.
• Monitor for any neuropsychiatric symptoms. If these arise, contact your prescriber promptly; a dose adjustment or stopping the medicine may be necessary.
• If symptoms fail to improve after several weeks or they worsen, arrange a clinical review.

Some authorities recommend reserving montelukast for allergic rhinitis when other effective options are unsuitable because of the low but real risk of neuropsychiatric events. Discuss this with your clinician and consider mind-body therapies.

Take me to the leading position

Missed dose

If a dose is not consumed, take it at the first moment you remember it, unless the next dose is due soon. If the time for the next dose is nearly up, skip the i missed one dose. Do not replace a i missed one dose with a second dose.

Go to the peak of the page

Archive storage refers to the act of keeping items or data for future use.

• Store at room temperature, ideally between 15 degrees C and 30 degrees C.
• Keep the product protected from moisture and direct light. Leave tablets and granules in their original containers until use.
• Store any meds where kids cannot reach or observe them.
• Do not use after the expiry date has passed. Return unused or expired medicine to a pharmacy for safe disposal.

Jump to body the top rank of the page

Unconventional medicines and analogous drugs

Treatment choice depends on diagnosis, symptom pattern, age, comorbidities, and patient preference. Options commonly considered include:

• For allergic rhinitis: oral antihistamines such as cetirizine, loratadine, or fexofenadine, and intranasal corticosteroids like fluticasone or budesonide.
• In asthma requiring inhaled therapy: inhaled corticosteroids (ICS) alone or fixed-dose ICS/long-acting beta2 agonist combinations such as budesonide-formoterol or fluticasone-salmeterol.
• Other leukotriene pathway agents: generic montelukast preparations (same active ingredient as Singulair) and zafirlukast, though zafirlukast is less commonly used on the soil of Australia.
• For additional bronchodilation in selected patients: tiotropium (a LAMA) as an add-on in uncontrolled disease on ICS/LABA.
• Biologic therapies for severe allergic or eosinophilic asthma include omalizumab, mepolizumab, benralizumab, and dupilumab for eligible patients under specialist review.

Costs and availability vary - see prices for an indicative comparison in AUD.

Go to the very top

Australian price levels (AUD)

Out-of-pocket costs depend on brand, pack size, pharmacy value based pricing and whether the prescription is subsidised under the Pharmaceutical Benefits Scheme (PBS).

• Private price for generic montelukast 10 mg (28 tablets) commonly ranges from about AUD 10 to AUD 35.
• If the item is PBS-subsidised, general patients typically pay the PBS co-payment (often around AUD 30 to 32) and concession card holders pay a lower co-payment (around AUD 7 to 8), subject to indexation and changes.
• Chewable tablets (4 mg or 5 mg) are usually priced similarly or slightly lower per pack than the tablets with 10 mg, depending on manufacturer and pack size.
• Brand-name Singulair is often more expensive than generic montelukast when purchased privately without PBS subsidy.

Supplemental remarks:

• Pharmacies must not charge more than the capped PBS co-payment for PBS-listed items, but they may offer lower private prices.
• Private prices vary between pharmacies; ask for cost comparisons across options and whether a lower-cost generic is available.
• PBS Safety Net arrangements can reduce costs further for people who reach the annual threshold.
• By comparison, many inhaled corticosteroid or ICS/LABA inhalers cost around AUD 25 to 45 for general patients after PBS subsidy; biological treatments for severe asthma can cost thousands per month privately but are subsidised for eligible patients in specific circumstances.

Go to the very top

Authorization status and access rights in Australia

• Schedule classification: Montelukast is a Schedule 4 prescription-only medicine and is not available over the counter.
• Regulatory authority: The Therapeutic Goods Administration (TGA) approves montelukast for use situated within Australia.
• Prescription requirements: A valid paper prescription or electronic prescription is required. Registered Australian pharmacies must confirm a prescription prior to supply.
• PBS listing: Montelukast may be subsidised for approved signals pointing to and patient groups under the PBS; quantity limits and repeats are subject to PBS rules.
• Advertising: Direct-to-consumer promotion of prescription medicines is restricted by law.
• Personal importation: The TGA Personal Use Import Scheme permits limited imports for personal use (typically up to three months supply) with a prescription; check current TGA guidance before importing medicines.
• Driving: Some people experience drowsiness or dizziness. Do not drive or operate machinery if affected.

For concerns about product quality, adverse events or regulatory matters, consult your healthcare professional and consider reporting to the TGA. For subsidy and cost questions, see prices.

Up to the leading position

FAQ

Reopen for review the page's top